Ryah Group Inc. Uses Big Data, AI to Reshape Plant-Based Medicine 

  • RYAH recognizes the value data combined with analytics can bring to almost every industry.
  • Company focused on becoming a technological leader in the plant-based treatment market.
  • RYAH’s easy-to-operate line of products help foster a seamless dose-control experience that generates insightful data.

A recent Forbes article called it the “oil” of the fourth industrial revolution (https://cnw.fm/VKdtU) while a Gartner article noted it was a core function for businesses focused on success in 2021 (https://cnw.fm/O3Zvf). Whatever it is called, data has become a hot commodity in today’s world, and the RYAH Group is dedicated to transforming patient care through big data and AI to unearth breakthrough discoveries that will reshape understanding of plant-based medicines.

“Self-driving cars, lifelike robots, and autonomous delivery drones are the sexy, headline-grabbing face of the digital transformation that we see all around us today,” stated the “Forbes” article. “None of these would be possible, though, without data – the oil of the fourth industrial revolution – and the analytic technology we’ve built to allow us to interpret and understand it.”

The Gartner article noted that “business leaders are beginning to understand the importance of using data and analytics to accelerate digital business initiatives. Instead of being a secondary focus — completed by a separate team — data and analytics is shifting to a core function. However, business leaders often underestimate the complexities of data and end up missing opportunities.”

RYAH recognizes the value data combined with analytics can bring to almost every industry, and it has focused on becoming a technological leader in the plant-based treatment market. The company has created unique products that pair a growing ecosystem of therapeutic plants with top-rated apps, devices, and services.

RYAH’s easy-to-operate line of products help foster a seamless dose-control experience that generates insightful data, making it simple for doctors, researchers, and end users to hone in on the ideal settings for the best possible treatment outcomes with RYAH Smart Patch, RYAH Smart Inhaler, RYAH Smart Pen, and upcoming RYAH MD platform.

These proprietary IoT devices and data analytics are supported by patented AI technology to aggregate and correlate HIPAA-compliant dosing data from seed to consumption. RYAH is then able to conduct predictive analyses to help doctors, researchers and end users create personalized dosing regimens that can accurately foresee patient outcomes.

RYAH’s unique approach has allowed it to carve a promising niche in the $100.3 billion medical plant market, with exciting potential in both the IoT and data intelligence industries.

For more information, visit the company’s website at www.RYAHGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://cnw.fm/RYAH

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.canadiancannabiswire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.canadiancannabiswire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CanadianCannabisWire is part of the InvestorBrandNetwork.

Archives

Select A Month

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977